Press releases

  2020/12/16 08:00AM
|

Quantum Genomics Signs a Strategic Contract with Delpharm

  2020/12/15 08:00AM
|

Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Faran

  2020/12/03 08:15AM
|

Very successfull Private Placement

  2020/12/02 5:45PM
|

Quantum Genomics Strengthens its Capital Structure and Financial Visibility

  2020/12/02 5:40PM
|

Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with DongWha Pharm

  2020/11/02 6:00PM
|

Quantum Genomics Announces End of Financing Agreement with Negma Group Ltd/Park Partners

  2020/10/28 08:00AM
|

Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Xediton Pharmaceuticals

  2020/10/19 08:00AM
|

Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Qilu Pharmaceutical

  2020/09/22 6:00PM
|

Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Orient EuroPharma (OEP)

  2020/07/13 08:00AM
|

Quantum Genomics Enrolls First Patient in Its Pivotal Phase III FRESH Trial of Firibastat in Difficult-to-treat and Resistant Hypertension

  2020/05/06 6:00PM
|

Quantum Genomics Announces Interim Analysis from Study of Firibastat in Renal Failure Patients

  2020/04/07 6:00PM
|

Quantum Genomics Provides Update on the Impact of the COVID-19 Health Crisis on Clinical Research Activities

  2020/03/26 6:15PM
|

Quantum Genomics Secured New Financing, Published its Financial Statements for Fiscal Year 2019 and Provides 2019 Highlights

  2020/01/28 07:30AM
|

Quantum Genomics Appoints Benoît Gueugnon as Vice President of Finance

  2020/01/15 6:00PM
|

Quantum Genomics to Present at the Gordon Research Conference 2020 Dedicated to the Renin Angiotensin Aldosterone System